Di Peng, Zhang Lei, Chen Junfeng, Tan Hexin, Xiao Ying, Dong Xin, Zhou Xun, Chen Wansheng
Department of Pharmacy, Changzheng Hospital, ‡Department of Pharmacognosy, School of Pharmacy, §Department of Drug Analysis, School of Pharmacy, and ∥Modern Research Center for Traditional Chinese Medicine, Second Military Medical University , Shanghai 200003, China.
ACS Chem Biol. 2013 Jul 19;8(7):1537-48. doi: 10.1021/cb3006962. Epub 2013 May 7.
Rosmarinic acid (RA) and lithospermic acid B (LAB) are two typical phenolic acids with significant bioactivities that may contribute to the therapeutic effects of Salvia miltiorrhiza. Precise knowledge of the biosynthetic pathway leading to RA and LAB is a necessary prerequisite to optimize the production of important phenolic compounds in S. miltiorrhiza. In vivo isotopic labeling experiments using [ring-(13)C]-phenylalanine, combined with dynamic measurements of metabolite levels by UPLC/Q-TOF, were used to investigate the metabolic origin of phenolic acids in S. miltiorrhiza. These data indicate the in vivo phenolic biosynthetic pathway: two intermediates from the general phenylpropanoid pathway and the tyrosine-derived pathway, 4-coumaroyl-CoA and 3,4-dihydroxyphenyllactic acid (DHPL), are coupled by the ester-forming enzyme rosmarinic acid synthase (SmRAS) to form 4-coumaroyl-3',4'-dihydroxyphenyllactic acid (4C-DHPL). The 3-hydroxyl group is introduced late in the pathway by a cytochrome P450-dependent monooxygenase (SmCYP98A14) to form RA. Subsequently, RA is transformed to a phenoxyl radical by oxidation, and two phenoxyl radicals unite spontaneously to form LAB. The results indicate aspects of the complexity of phenolic acid biosynthesis in S. miltiorrhiza and expand an understanding of phenylpropanoid-derived metabolic pathways. The candidate genes for the key enzymes that were revealed provide a substantial foundation for follow-up research on improving the production of important phenolic acids through metabolic engineering in the future.
迷迭香酸(RA)和紫草酸B(LAB)是两种具有显著生物活性的典型酚酸,可能有助于丹参的治疗效果。准确了解导致RA和LAB的生物合成途径是优化丹参中重要酚类化合物产量的必要前提。使用[环-(13)C]-苯丙氨酸进行体内同位素标记实验,并结合超高效液相色谱/四极杆飞行时间质谱(UPLC/Q-TOF)对代谢物水平进行动态测量,以研究丹参中酚酸的代谢起源。这些数据表明了体内酚类生物合成途径:来自一般苯丙烷途径和酪氨酸衍生途径的两种中间体,4-香豆酰辅酶A和3,4-二羟基苯乳酸(DHPL),通过酯形成酶迷迭香酸合酶(SmRAS)偶联形成4-香豆酰-3',4'-二羟基苯乳酸(4C-DHPL)。3-羟基在该途径后期由细胞色素P450依赖性单加氧酶(SmCYP98A14)引入以形成RA。随后,RA通过氧化转化为苯氧自由基,两个苯氧自由基自发结合形成LAB。结果表明了丹参中酚酸生物合成的复杂性,并扩展了对苯丙烷衍生代谢途径的理解。所揭示的关键酶的候选基因为未来通过代谢工程提高重要酚酸产量的后续研究提供了坚实基础。